Skip to Main Navigation
Skip to Page Content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/10937

Procarbazine hydrochloride: Target Organs and Levels of Evidence for TR-019

Bioassay of Procarbazine for Possible Carcinogenicity (CASRN 366-70-1)

Chemical (Study Title)
CASRN
Peer Review DateRoute/Exposure LevelsStudy Laboratory
Procarbazine hydrochloride
366-70-1
NAIntraperitoneal Injection
R: 0,15,30, M: 0,6,12 MG/KG/35 PER GROUP
Southern Research Institute

Levels of Evidence

Male Rats: Positive
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Hematopoietic System: (LYMPHOMA OR LEUKEMIA)
  • Mammary Gland: (ADENOCARCINOMA)
  • Brain: (ADENOCARCINOMA, NEUROBLASTOMA, CARCINOMA)
Female Rats: Positive
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Hematopoietic System: (LYMPHOMA)
  • Mammary Gland: (ADENOCARCINOMA)
  • Brain: (NEUROBLASTOMA)
Male Mice: Positive
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Hematopoietic System: (LYMPHOMA OR LEUKEMIA)
  • Brain: (NEUROBLASTOMA)
  • Lung: (ALVEOLAR/BRONCHIOLAR ADENOMA)
Female Mice: Positive
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Hematopoietic System: (LYMPHOMA OR LEUKEMIA)
  • Lung: (ALVEOLAR/BRONCHIOLAR ADENOMA)
  • Brain: (NEUROBLASTOMA)
  • Uterus/Cervix: (ADENOCARCINOMA)